Malignant Paraganglioma
4 clinical trials · Condition
◉ Watch Malignant Paraganglioma
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma (NCT04860700) | Peking Union Medical College Hospital | 2021-04-30 |
| Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery (NCT03008369) | Mayo Clinic | 2017-05-31 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer (NCT02592356) | M.D. Anderson Cancer Center | 2015-11-16 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
Track Malignant Paraganglioma automatically
Every clearance here is in the API, with alerts when new ones post.